DeepMed Research

AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA

🇮🇹Italy

Country: 🇮🇹Italy

Ownership: Private

Established: 1426-01-01

Employees: -

Market Cap: -

Website: http://www.ospedaleuniverona.it/ecm/home

Clinical Trials

Predictors of Disease Recurrence After Curative Surgery for Stage I Colon Cancer

Recruiting

Conditions: Colon Cancer Stage I
Colon Cancer

Interventions: Procedure: Colonic resection

First Posted Date: 2023-02-13

Last Posted Date: 2023-07-21

Lead Sponsor: Azienda Ospedaliera Universitaria Integrata Verona

Target Recruit Count: 2000

Registration Number: NCT05726188

Locations: 🇮🇹
Chirurgia Generale Colorettale, Ospedale degli Infermi, Faenza, Italy
🇮🇹
Chirurgia Generale 3, AOUI Padova, Padova, Italy
🇮🇹
UOC Chirurgia Generale 1, Policlinico Gemelli, Roma, Italy

and more 21 locations

The Study Aims to Investigate the Effects of Oral Inositols on Insulin-resistance in Children With Obesity.

Not Applicable

Not yet recruiting

Conditions: Insulin Resistance
Prediabetic State
Obesity
Dyslipidemias

Interventions: Dietary Supplement: INOSITOLS
Dietary Supplement: CELLULOSE

First Posted Date: 2023-01-27

Last Posted Date: 2023-01-27

Lead Sponsor: Azienda Ospedaliera Universitaria Integrata Verona

Target Recruit Count: 56

Registration Number: NCT05701813

Clinical and Economic Validation of the ISGPS Definition of PPAP

Completed

Conditions: Postoperative Acute Pancreatitis
Postoperative Complications
Pancreaticoduodenectomy
Postoperative Pancreatic Fistula

Interventions: Diagnostic Test: PPAP diagnosis

First Posted Date: 2023-01-11

Last Posted Date: 2024-01-16

Lead Sponsor: Azienda Ospedaliera Universitaria Integrata Verona

Target Recruit Count: 2900

Registration Number: NCT05680623

Locations: 🇮🇹
Giovanni Marchegiani, Verona, Italy

Osteoporosis and Fragility Fractures Among SLE Patients. (FRAIL Trial)

Active, not recruiting

Conditions: Lupus Erythematosus, Systemic

First Posted Date: 2022-10-21

Last Posted Date: 2024-08-06

Lead Sponsor: Azienda Ospedaliera Universitaria Integrata Verona

Target Recruit Count: 300

Registration Number: NCT05590390

Locations: 🇮🇹
AOUI Verona - UOC Reumatologia, Verona, Italy

Effect of CGM With Predictive Alarm on Hypoglycemia in Young Patients With T1D.

Not Applicable

Completed

Conditions: Type 1 Diabetes

Interventions: Device: Use of Predictive Alarm for hypoglycaemia or hyperglycaemia
Device: Use of Alarm on Threshold for hypoglycaemia or hyperglycaemia

First Posted Date: 2022-10-10

Last Posted Date: 2022-10-10

Lead Sponsor: Azienda Ospedaliera Universitaria Integrata Verona

Target Recruit Count: 20

Registration Number: NCT05574023

Locations: 🇮🇹
Pediatric Diabetes and Metabolic Disorders Unit, Surgery, Dentistry, Paediatrics and Gynaecology, University of Verona, 1 Piazzale Stefani, Verona, Italy

Management of Preoperative Anaemia in Surgical Oncology

Phase 4

Conditions: Anemia
Tumor

Interventions: Drug: Ferric Carboxymaltose Injection
Drug: Folic acid
Drug: B12

First Posted Date: 2022-08-17

Last Posted Date: 2022-08-19

Lead Sponsor: Azienda Ospedaliera Universitaria Integrata Verona

Target Recruit Count: 500

Registration Number: NCT05505006

Locations: 🇮🇹
Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy

Physical and Cellular Effects of Ultra-cycling

Completed

Conditions: Endurance Training

Interventions: Diagnostic Test: clinical evaluation, bioelectrical impedance analysis (BIA), cardiopulmonary exercise testing (CPET) and venipuncture for blood samples collection

First Posted Date: 2022-06-21

Last Posted Date: 2022-06-21

Lead Sponsor: Azienda Ospedaliera Universitaria Integrata Verona

Target Recruit Count: 8

Registration Number: NCT05424588

Locations: 🇮🇹
AOUI, Verona, Italy

Study of Adherence to Antihypertensive Drugs and Statins by Hair Analysis

Conditions: Arterial Hypertension
Dyslipidemias
Antihypertensive Drugs
Statins
Treatment Adherence

First Posted Date: 2022-04-26

Last Posted Date: 2022-05-02

Lead Sponsor: Azienda Ospedaliera Universitaria Integrata Verona

Target Recruit Count: 200

Registration Number: NCT05347823

Locations: 🇮🇹
Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy

Non-inferiority Trial on Treatments in Early COVID-19

Phase 3

Completed

Conditions: COVID-19

Interventions: Drug: Nirmatrelvir Ritonavir
Drug: Tixagevimab Cilgavimab
Drug: Sotrovimab

First Posted Date: 2022-04-11

Last Posted Date: 2023-11-07

Lead Sponsor: Azienda Ospedaliera Universitaria Integrata Verona

Target Recruit Count: 536

Registration Number: NCT05321394

Locations: 🇮🇹
Azienda Ospedaliera Cannizzaro, Catania, Italy
🇮🇹
Azienda Ospedaliera dei Colli, presidio ospedaliero Cotugno, Napoli, Italy
🇮🇹
Azienda Ospedaliera S. Maria della Misericordia, Perugia, Italy

and more 16 locations

PIPAC in Multimodal Therapy for Patients with Oligometastatic Peritoneal Gastric Cancer

Phase 3

Recruiting

Conditions: Oligometastatic Gastric Adenocarcinoma

Interventions: Combination Product: FOLFOX and PIPAC

First Posted Date: 2022-03-31

Last Posted Date: 2025-02-21

Lead Sponsor: Azienda Ospedaliera Universitaria Integrata Verona

Target Recruit Count: 98

Registration Number: NCT05303714

Locations: 🇮🇹
AOUI Verona, Verona, Italy

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy